This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024



Company Description

Ilonov is a preclinical stage biotech developing first-in-class biotherapies against diabetes, harvesting the breakthrough potential of the muscle secretome to regulate metabolism, a novel and unexplored approach. Our strategy is based on a high-risk high-reward approach aiming first at developing a functional cure by potentiating pancreatic islet transplant and next generation beta cell replacement therapies to treat Type 1 Diabetes. Follow on indications include T2D & metabolic diseases.